Scripsamerica EBITDA 2013-2015 | SCRCQ

Scripsamerica ebitda from 2013 to 2015. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Scripsamerica Annual EBITDA
(Millions of US $)
2014 $-4
2013 $-7
2012 $-2
Scripsamerica Quarterly EBITDA
(Millions of US $)
2015-03-31 $-1
2014-12-31
2014-09-30 $2
2014-03-31 $0
2013-12-31
2013-09-30 $-3
2012-12-31
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.000B $0.000B
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs. The Company is focused on pharmaceutical supply chain management services, from strategic sourcing to delivering niche generic pharmaceuticals to market. It delivers pharmaceutical products to a range of end users across the health care industry, including physicians' offices, retail pharmacies, long-term care sites, hospitals, and Government and home care agencies. The Company's therapeutic categories include pain, arthritis, prenatal, urinary and hormonal replacement drugs. ScripsAmerica, Inc. is based in Tysons Corner, Virginia.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $87.363B 23.91
Becton Dickinson (BDX) United States $57.057B 14.28
Cardinal Health (CAH) United States $32.542B 17.43
Straumann Holding AG (SAUHY) Switzerland $18.704B 0.00
Labcorp (LH) United States $18.166B 14.90
Cooper (COO) United States $15.901B 21.09
West Pharmaceutical Services (WST) United States $14.596B 29.91
Align Technology (ALGN) United States $12.549B 24.31
Henry Schein (HSIC) United States $7.930B 13.66
Merit Medical Systems (MMSI) United States $5.369B 26.12
Patterson (PDCO) United States $2.772B 15.98
DENTSPLY SIRONA (XRAY) United States $2.557B 7.68
CONMED (CNMD) United States $1.503B 11.68
STAAR Surgical (STAA) United States $0.833B 0.00
Pro-Dex (PDEX) United States $0.198B 30.26
Lifevantage (LFVN) United States $0.169B 18.65